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Abstract
Dietary folates have a key role to play in health as defciencies in the intake of these B vitamins have
been implicated in a wide variety of clinical conditons. The reason for this is folates functon as
single carbon donors in the synthesis of methionine and nucleotdes. Moreover, folates have a vital
role to play in the epigenetcs of mammalian cells by supplying methyl groups for DNA methylaton
reactons. Intriguingly, a growing body of experimental evidence suggests DNA methylaton status
could be a central modulator of the ageing process. This has important health implicatons because
the methylaton status of the human genome could be used to infer age-related disease risk. Thus, it
is imperatve we further our understanding of the processes which underpin DNA methylaton and
how these intersect with folate metabolism and ageing. The biochemical and molecular mechanisms
which underpin these processes are complex.  However,  computatonal modelling ofers an ideal
framework for handling this complexity. A number of computatonal models have been assembled
over the years, but to date no model has represented the full scope of the interacton between the
folate cycle and the reactons which govern the DNA methylaton cycle. In this review we will discuss
several of the models which have been developed to represent these systems. In additon we will
present a ratonale for developing a combined model of folate metabolism and the DNA methylaton
cycle. 
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Introducton 
The term ‘folate’ (vitamin B9) is used to denote a group of compounds which possess the same
vitamin actvity and includes natural folates as well as the pharmacological compounds folic acid and
folinic acid [1]. The dietary importance of folate cannot be overstated. This is emphasized by the
wide  range  of  clinical  disorders  which  correlate  with  low  folate  status  [2-4].  In  additon,
polymorphisms in genes coding for folate dependent enzymes [5,  6] are associated with several
cancers (cervical, bronchial, colon and breast) [7-10], Alzheimer’s disease [11], Down syndrome [12],
unexplained  recurrent  early  pregnancy  loss  and  pre-eclampsia  [13].These  associatons  are
unsurprising when one considers that folates are involved in a ubiquitous array of cellular processes.
oor instance, folates are involved in the synthesis of nucleotdes from purine precursors, partcipate
indirectly  in  the  synthesis  of  transfer  RNA and functon as  single  carbon donors  during  the re-
methylaton of homocysteine (Hcy) to methionine [14] (oigure 1). oolate-derived one-carbon units
also play a central role in DNA methylaton [15, 16]. This epigenetc process involves methyl groups
covalently bonding to CpG dinucleotdes to establish tssue specifc methylaton paterns.  A CpG
dinucleotde consists of a deoxycytdine followed by a deoxyguanidine, with the “p” indicatng the
phosphate  group  between these  nucleotdes.  Covalent  bonding  of  methyl  groups  occurs  at  the
carbon-5 positon of a deoxycytdines to create a methylated CpG dyad [11, 12]. Dynamic changes to
methylaton paterns are an important gestatonal phenomenon, which regulate gene expression
during  embryonic  development  [17].  However,  during  adult  life  alteratons  to  DNA methylaton
paterns can have signifcant implicatons for the onset of disease [18, 19]. Specifcally, advancing
age  is  ofen  accompanied  by  global  hypomethylaton  [20-23]  in  conjuncton  with  site  specifc
hypermethylaton at the promoter region of a variety of genes [24-27]. Hypermethylaton, involves
CpG islands (~500-2000 base pairs) within the promoter becoming excessively methylated [28, 29],
and  ofen  occurs  with  concomitant  transcriptonal  silencing  [30,  31].  Gene  promoter
hypermethylaton is a feature of certain diseases, the most notable being cancer [25]. oor instance,
Wang  et al. (2016) [32] recently found that  DNA methylaton changes during ageing were closely
correlated to the occurrence of  cancer.  In  additon to cancer  aberrant  DNA methylaton has  an
emerging role to play in many age related diseases including, cardiovascular disease (CVD) [33],
Alzheimer’s disease [34] and osteoporosis/osteoarthrits [35]. Such fndings consolidate the growing
view that DNA methylaton status and health-span are inexorably entwined. Moreover it has also
been  revealed  that  investgatng  changes  to  the  methylaton  profle  of  the  genome  could  help
develop our understanding of ageing.  This  asserton is supported by the recent bioinformatcs work
of Horvath (2013) [36] who utlized publicly available methylaton data sets to identfy an “epigenetc
clock “ underpinned by  methylaton changes in  353 CpGs.  Intriguingly,  Horvarth postulates  that
“DNA methylaton age” measures the cumulatve efect of an epigenetc maintenance system. This
fnding indicates that a deeper mechanistc understanding of DNA methylaton preservaton could be
pivotal to improving our overall understanding of ageing and health-span.  
To extend our understanding of DNA methylaton and its bidirectonal relatonship with ageing it is
imperatve we consider how subtle alteratons to folate one carbon metabolism (oOCM) impact the
regulatory processes which govern DNA methylaton. Specifcally, it is necessary to explore how such
perturbatons afect gene promoters which are susceptble to hypermethylaton. In additon, it is
vital we consider how other factors associated with ageing impact this relatonship. However, this is
not a straightorward task as both oOCM and the DNA methylaton cycle are complex processes
which are underpinned by a large number of biochemical and molecular reactons (oigure 1). Many
of  these  reactons  are  non-linear  in  nature  and  are  infuenced  by  a  variety  of  other  B
vitamins/nutrients and enzymatc cofactors [37].  Ageing  adds a further  degree of  complexity  by
altering the dynamics of the reactons. oor example, age-dependent decreases in the expression
levels/actvity  of  human  methionine  synthase  (MS)  and  methylenetetrahydrofolate  reductase
(MTHoR) have been observed [38, 39]. Both enzymes are recognised as key regulators of oOCM and
expression/actvity changes potentally afect their reacton kinetcs. Similarly, the actvity of human
DNA methyltransferase 1  (Dnmt 1),  a  key enzyme involved in  the additon of  methyl  groups to
cytosine residues, has also been observed to decrease with age [40]. Moreover, ageing also afects
the availability  of  cofactors  such as vitamin B12 [41],  which is  central  to oOCM, while oxidatve
stress, which is generally regarded as a key contributor to ageing, has been observed to efect both
DNA methylaton and oOCM [42,  43].  ourthermore,  it  is  not  uncommon that older  people have
diminished folate status as a result of a low dietary intake of the vitamin [44]. Thus, it is necessary to
consider an array of factors when investgatng the maintenance of DNA methylaton. oortunately,
there is a growing appreciaton that complex biological process can be studied in a holistc manner
by adoptng a systems biology approach [45]. Computatonal modelling resides at the centre of this
paradigm shif as it provides a framework for representng and exploring the dynamics of complex
systems [46-50]. In this review we discuss the role computatonal modelling has played in developing
our understanding of oOCM and DNA methylaton. In additon we propose coupling oOCM and the
DNA methylaton cycle into one computatonal model, which could be used to further explore the
dynamics of their relatonship. 
oolate metabolism and the DNA methylaton Cycle
oOCM is fundamentally important to DNA methylaton. Various folates are the cofactors for the de
novo synthesis of methyl groups from more oxidized one carbon units and 2) the methyl groups on
5-methyltetrahydrofolate  are  used  to  re-methylate  hcy  to  methionine  and  to  regenerate
tetrahydrofolate,  the  metabolically  actve  form  of  folate.  Methionine  is  a  precursor  of  S-
adenosylmethionine (SAM), which has a predominant role to play in the majority of biochemical
methyl donaton events, including that of DNA methylaton. Post replicaton, Dnmt1 uses SAM as a
substrate  to  transfers  methyl  groups  to  the  DNA  molecule  [51]  this  produces  S-
adenosylhomocysteine  (SAH).  SAH is  then  converted  to  Hcy  permitng  the  contnuaton of  the
methylaton cycle  [52,  53]  (oigure  1).  In  conjuncton with  Dnmt1 DNA methylaton paterns are
dynamically  regulated  by  several  other  enzymes  (oigure  1).  As,  Dnmt1  preferentally  acts  on
hemimethylated  DNA and  is  potentally  unable  to  methylate  neo-synthesized  DNA strands,  this
enzyme is generally regarded as solely a maintenance enzyme [54].Thus, other enzymes are needed
to  perform  de  novo DNA  methylaton.  Dnmt3a  and  Dnmt3b  are  widely  regarded  as  the  main
enzymes responsible for this  role [55, 56].  These methylaton reactons are ofset by actve and
passive demethylaton. Passive demethylaton occurs during replicaton, while actve methylaton
can involve ten eleven translocaton (TET) dioxygenases, which oxidize the methyl groups of cytosine
[57]. TET are thought to functon by oxidizing the methyl groups of cytosine. This process eventually
culminates with the reintroducton of unmethylated cytosine in the DNA molecule [57].  Thus,  it
would appear that the steady state levels of both site specifc and global DNA methylaton paterns
are  maintained  by  an  antagonistc  balancing  act  between  those  actvites  responsible  for
maintenance/de  novo  methylaton  and  those  reactons  responsible  for  passive/actve
demethylaton.  Moreover,  methylaton  fdelity  studies  suggest  these  processes  are  subject  to
inherent  stochastcity.  oor  example,  Landan  et  al.  (2012)  [58]  tracked  the  in  vitro evoluton of
immortalized  fbroblasts  for  >300  generatons  and  found  that  changes  in  populaton-averaged
methylaton occur through a stochastc process. In additon, Shipony et al. (2014) [59] suggest the
persistence nature of the somatc methylome is one factor which makes it increasingly vulnerable to
noise with tme. This is intriguing from the perspectve of ageing as it would appear that in young
somatc cells, site specifc methylaton density is characterised by low level noise, which maintains
average  methylaton density.  Therefore,  the  persistent  nature  of  the  methylome and  increased
stochastcity with tme could  contribute to the formaton of  aberrant DNA methylaton paterns
which are a hallmark of the ageing process in humans. 
Computatonal Models of oolate Metabolism 
The models described in the next two sectons are summarised in Table 1 and 2 respectvely. Models
of oOCM have traditonally adopted a contnuous deterministc approach, with the dynamics of the
system  being  represented  by  ordinary  diferental  equatons  (ODEs),  which  are  underpinned  by
kinetc reactons [60]. In the main reacton velocites are assumed to depend on the concentratons
of the reacton substrates (the law of mass acton [61]). Rate laws for more complex reactons laws
are  in  general  described  by  Michaelis–Menten  kinetcs  [62]  for  one,  two,  or three  substrates
assuming  a  random-order  mechanism.  The following  mathematcal  expressions  taken  from  the
recent model by Salcedo-Sora and Mc Auley (2016) [63] encapsulate the diferent Michaelis–Menten
based functonal forms as used for one , two, and three substrates in these types of kinetc models,
where V is the velocity of the reacton, Vmax, is the theoretcal maximum velocity of the reacton, S1
to S3 are substrates and km1 to km3 are the substrate concentratons at which the reacton is half
maximum velocity. 
The  frst  mathematcal  model  to  adopt  this  kinetc  approach  to  represent  intracellular  folate
metabolism was developed in the 1970s and had a strong pharmacological theme [64]. It was used
to simulate the actons of methotrexate on DNA synthesis. The next signifcant computatonal model
of the folate cycle, was developed by Nijhout  et al. (2004) [65]. This model is underpinned by the
enzyme kinetc data that characterises the reactons in oigure 1, and was assembled using the type
of  mathematcal  equatons  outlined  above.  As  well  as  being  the  frst  detailed  mathematcal
descripton  of  the  folate  cycle,  model  simulatons  were  able  to  quanttatvely  reproduce  the
intracellular levels of the various folate metabolites and the model was able to predict the efect of
vitamin B12 defciency. Building on this work, Reed et al. (2006) [66] used this model combined with
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models  of  methionine  metabolism  [67,  68]  to  investgate  genetc  polymorphisms  in  the  folate
pathway. Polymorphisms in MTHoR predicted a reducton in MTHoR actvity reduces concentratons
of SAM and 5-MTHR, and DNA methylaton, while slightly increasing SAH and hcy concentratons and
thymidine or purine synthesis. Decreased folate together with a simulated vitamin B12 defciency
resulted in decreased DNA methylaton and purine and thymidine synthesis. This model was also
used as  a  template  to  study  the  efect  of  intracellular  folate  defciency  and  excess.  The model
suggested  that  the  enzyme  thymidylate  synthesis  is  very  sensitve  to  changes  in  epithelial
intracellular folate and increased signifcantly under conditons of high intracellular folate [69]. This
framework was further extended by Duncan et al. (2013) [70] to hepatc and plasma folate turnover.
It was applied to a populaton of virtual individuals and showed that tssue and plasma folate is
highly  correlated,  but  liver  and plasma folate  much less  so.  Moreover,  this  model  showed that
oxidatve stress increases the plasma S-adenosylmethionine/S-SAM/SAH rato. The most recent ODE
model of folate metabolism was developed by Salcedo-Sora and Mc Auley (2016) [63]. Our model is
the frst computatonal model of microbial folate biosynthesis and utlisaton. Using the model we
were  able  to  identfy  specifc  targets  within  folate  metabolism  which  synergise  with  current
antfolates. In additon the results from our model support experimental fndings which suggest the
folinic  acid  substrate  cycle  is  an  important  biochemical  mechanism  deployed  during  actve  cell
growth. A key fnding which emphasizes the utlity of computatonal models for shedding light on
this complex system. 
Computatonal Models of the DNA Methylaton Cycle
A variety of approaches have been used to model various aspects of DNA methylaton [71-79]. Our
focus is the precise representaton of the DNA methylaton cycle. To this end the DNA methylaton
cycle has been modelled explicitly by McGovern et al. (2012) [80]. The model centred on the actvity
of DNMTs and partal diferental equatons was used to represent methylaton reactons. It  was
used as a predictve tool for haematological malignancies. The model was able to predict the relatve
abundances of unmethylated, hemimethylated, fully methylated, and hydroxymethylated CpG dyads
in  the  DNA  of  cells  with  fully  functonal  methylaton  and  TET  enzymes.  In  additon  to  this
deterministc framework stochastc models of the methylaton cycle have also been used to study
the methylaton cycle. The goal has been to derive models which account for the noise associated
with  maintaining  DNA  methylaton  levels.  oor  example,  a  reduced  probabilistc  mathematcal
representaton of methylaton dynamics (known as the standard/classical model) has been proposed
by Pfeifer  et  al. (1990)  [81],  and  further  utlised  by  Riggs  and  Xiong  (2004)  [82].  This  model  is
presented in equatons 4-7. 
To briefy explain ODEs 4 and 5, and equatons 6 and 7, M is a CpG site, U is its unmethylated state,
Ed is the efciency of de novo methylaton, Em is the efciency of maintenance methylaton, M is the
number of methylated sites,  M∧ is  the fracton of  methylaton, while equaton 7 represents the
steady state soluton to ODEs 4 and 5 when dM∧/dt=0. This model is underpinned by the idea that
site  specifc  methylaton  levels  are  underscored  by  a  stochastc  process,  where  de novo and
maintenance methylaton actvity are central. Recently Jeltsch and Jurkowska (2014) [83] provided
an intriguing theoretcal extension to this concept. Jeltsch and Jurkowska propose a stochastc model
which  also  includes  the  rate  of  cell  division  together  with  passive  and  actve  demethylaton
(equaton 8). 
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methylaton by replicaton and actve demethylaton (
i
demethr ) at this site. D, is the rate of cell division,
i
mainf  is the efciency of maintenance methylaton at site i.  
According to the authors, equaton 8 has the signifcant advantage over its predecessor as it includes
the possibility of proofreading/repair mechanisms due to the incorporaton of negatve feedback.
This level of regulaton is atained because an increase in methylaton causes a reducton in the frst
term of equaton 8 with a subsequent increase in the second term. Consequently the methylaton
rate drops and demethylaton increases, resultng in a stable steady-state methylaton level at each
site. To our knowledge this theoretcal framework has yet to be applied to experimental data or
simulated dynamically. A stochastc mathematcal framework also inspired Haerter et al. (2014) [84]
to create a computatonal  model of  this  system. Their  model difers from the classical/standard
model as it included dynamic collaboraton between CpGs. More recently Olariu  et al. (2016) [85]
built  on  the  work  of  Haerter  et  al.  (2014)  to  model  the  regulaton  of  transcripton  and  DNA
methylaton.
Ratonale for Computatonally Integratng oOCM and the DNA Methylaton Cycle
Computatonal models of oOCM are not fully integrated with the DNA methylaton cycle. Rather, as
outlined they have been restricted to the cycle itself or its involvement with DNA synthesis and have
tended  not  to  include  the  DNA  methylaton  cycle.  Some  have  atempted  to  account  for  DNA
methylaton but no model to our knowledge has explicitly integrated both systems in a meaningful
way.  We  propose  computatonally  integratng  oOCM  and  the  methylaton  cycle.  Our  biological
ratonale is unpinned by the knowledge that perturbatons in the folate cycle are strongly coupled
with aberrant DNA methylaton. This  is  evidenced by the associaton between low folate status,
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global  DNA hypomethylaton and increased cancer  risk  [86].  In  additon,  genetc polymorphisms
most  notably  in  the  MTHoR  gene,  which  codes  for  MTHoR,  an  enzyme  which  catalyses  the
conversion of 5, 10-methylenetetrahydrofolate to 5-methyltetrahydrofolate (5-MToHo) (oigure 1) is
associated  with  gene  promoter  hypermethylaton [87].  Moreover,  methionine  synthase  A2756G
(MTR A2756G) is a common polymorphism in the gene encoding MS. This enzyme catalyses the
regeneraton of methionine from hcy and disruptons to its enzymatc capabilites also emphasise the
close link between folate metabolism and disruptons to DNA methylaton. oor instance, Weiner and
colleagues  (2014)  [87]  found that  individuals  homozygous  for  this  mutant  allele  showed higher
leukocyte genomic DNA methylaton levels than individuals possessing the wild-type genotype (MTR
2756AA). It makes mechanistc sense that perturbatons of this nature to oOCM have an impact on
DNA  methylaton,  as  5-methyltetrahydrofolate,  is  a  cosubstrate  for  hcy  remethylaton  to
methionine, while MS modulates the dynamics of this reacton and perturbatons to this enzyme
result in a rise in plasma hcy [88], which is associated with CVD [89]. Intriguingly, a rise in plasma hcy
has also been associated with gene promoter hypermethylaton [90-93] and global hypomethylaton
[94-96] of human DNA. 
In  additon  to  perturbatons  due  to  genetc  mutatons  it  is  important  to  recognise  that  oOCM
compartmentalisaton could have implicatons for DNA methylaton status as compartmentalisaton
of oOCM has a role to play in regulatng the distributon of one-carbon units within the cell. The
parttoning of one-carbon units between nucleotde synthesis and hcy remethylaton is the focal
point  of  this  process,  where  methylenetetrahydrofolate  (MTHo)  is  at  the  centre  of  a  metabolic
competton [97, 98]. On the one hand MTHo is used as a cofactor during nucleotde synthesis to
facilitate the conversion of dUMP to dTMP by thymidylate synthase (TYMS). However, MTHo can
also be reduced and is then fully commited to the remethylaton of hcy. The separaton of oOCM
into  distnct  cellular  compartments  is  the  determining  factor  which  regulates  the  competton
between  TYMS  and  MTHoR  for  MTHo  [99].  This  regulaton  requires  the  trifunctonal,  enzyme
methylenetetrahydrofolate  dehydrogenase  (MTHoD1),  whose  actvity  depends  on  its  cellular
locaton [99]. The interdependence of this enzymes actvity to its locaton and its involvement in
regulatng the competton between MTHoR and TYMS is evident, when intracellular folate levels are
defcient, as insufcient levels of folate cause an accumulaton of MTHoD1 in the nucleus, when
compared to its cytosolic counterpart [100]. The nuclear build-up of MTHoD1 emphasises oOCM will
sacrifce hcy remethylaton in favour of nucleotde synthesis and underscores the regulatory role
compartmentalisaton plays in one-carbon metabolism. Intriguingly this aspect of oOCM could have
wider implicatons as recently it has been shown that changes to MTHoD1 can afect the regulaton
of DNA methylaton. Groth et al. (2016) [101] identfed a mutant (mthfd1-1) in Arabidopsis thaliana,
which carried a mutaton in cytoplasmic MTHoD1. This mutant sufered from accumulaton of hcy
and  SAM,  coupled  with  extensive  genome-wide  hypomethylaton.  Compartmental  regulaton  of
oOCM  is  also  highlighted  by  cyserine  hydroxymethyltransferase  (SHMT).  SHMT1  catalyses  the
conversion of tetrahydrofolate (THo) to 5, 10-methylenetetrahydrofolate and also converts serine to
glycine. It has been found that cytosine serine hydroxymethyltransferase (cSHMT1) preferentally
supplies one-carbon units for thymidylate synthesis [98, 102]. Mechanistcally, it is has been found
this  preference is  mediated by small  ubiquitn-like modifer (SUMO) modifcaton.  This  alteraton
enables the  translocaton of  SHMT to the nucleus and also modifes its catalytc capabilites [103].
Sumoylaton  could  also  be  crucial  to  both  DNA  methylaton  and  demethylaton  as  SUMO-1
modifcaton of DNMT1 had been shown to signifcantly enhance DNMT1 actvity [104]. It is also
possible sumoylaton is capable of modulatng the actvity of Dnmt3a and Dnmt3b [105]. This level of
crossover between oOCM and DNA methylaton consolidates the view that disruptons to oOCM
impact the dynamics of DNA methylaton/demethylaton events. However,  the full  extent of this
relatonship  remains to  be elucidated,  hence the growing need for  an integrated computatonal
model to explore the complex interactons of these systems. 
Theoretcal orameworks and Obstacles to Creatng a Combined Model 
To develop a combined model several theoretcal approaches could be adopted. oOCM could be
retained as a set of kinetc based ODEs, as is the case in the majority of models of this nature. It
would  then  be  straightorward  to  add  the  methylaton  cycle  as  ODEs  also  and  to  defne  the
combined system as a coupled set of ODEs. Despite the obvious computatonal advantages of this
simplifcaton,  these benefts are ofset by several  factors.  oirstly,  to assemble this  deterministc
model the ODEs need to be informed by kinetc data,  which accounts for the behaviour of  the
methylaton enzymes. This is not a straightorward task as parameter uncertainty is a signifcant
issue in  the feld  of  computatonal  systems biology.  As  outlined,  kinetc  based models  of  folate
metabolism tend to have rate laws where the velocity of a reacton assumes mass acton kinetcs or
is  based  on  an  enzyme  kinetc  law  (e.g.  Michaelis–Menten  kinetcs).  Unfortunately  kinetc
parameters  can  vary  signifcantly  depending  on  the  circumstances  in  which  their  kinetcs  were
quantfed and the biological source, with the possibility of model parameters varying by several
orders of magnitude depending on the partcular source [106]. Therefore, it is extremely unlikely
that a mathematcal model can be assembled from one biological source. This is highlighted by our
recent model of microbial folate metabolism, where the parameters were derived from a number of
sources [63]. It is also a feature of the mammalian computatonal models which have previously
relied on data from rat, mice and human studies [65]. Despite such pitalls, there is no alternatve to
this  approach of  determining model  parameters.  To this  end, a  number of  databases now exist
which archive kinetc data for the purpose of assembling computatonal models [107, 108]. We used
these  databases  to  identfy  a  series  of  indicatve  kinetc  parameters  for  the  model  outlined
diagrammatcally in oigure 1 and are summarised in Table 3. The identfcaton of these parameters
serve to emphasize that it is possible to assemble a combined kinetc model of folate metabolism
and the DNA methylaton cycle based on human data, however the data is limited. Moreover, we
were  able  to  identfy  kinetc  parameters  for  Dnmt1  and  Dnmt3A  [109,  110],  however  kinetc
informaton for the TET demethylaton enzymes could not be identfed. 
Although as outlined above it is clearly possible to assemble a combined deterministc kinetc model ,
given experimental evidence indicates DNA methylaton events are underscored by stochastcity a
kinetc based deterministc approach is not the correct way to model this aspect of the system. A
more accurate way is to incorporate noise into the model. The standard way of representng noise
within biological cells is to describe it mathematcally by a master equaton or to simulate molecule
fuctuatons by using a stochastc simulaton algorithm (SSA), such as the Gillespie algorithm or one
of its derivatves [111, 112]. Routnely embedded within the idea of intracellular noise is the concept
of  intrinsic  versus extrinsic  noise,  as developed experimentally  by Elowitz and colleagues (2002)
[113].  Within  this  context  intrinsic  noise  refers  to  the  variability  inherent  to  the  system  under
consideraton, while fuctuatons in those factors classifed as external to the system of interest are
responsible  for  extrinsic  noise  (oigure  2).  Specifcally,  this  mathematcal  approach  has  been
ubiquitously applied to the study of cell to cell variability in gene expression levels within isogenic
cell populatons [114-117]. 
Applying the above logic to our indicatve model it can be argued the reactons of the methylaton
cycle  are  responsible  for  generatng  intrinsic  noise  e.g.  the  inherent  statstcal  mechanical
fuctuatons  in  the  binding  and  difusion  dynamics  of  the  molecules  involved  in  maintaining
methylaton levels within a CpG island/gene body. Conversely, DNA methylaton/the epigenetc state
of the cell is considered to be a component of extrinsic noise when variatons in gene expression are
modelled in this way. We suggest extrinsic noise in our integrated model arises due to biochemical
fuctuatons originatng from the folate cycle and other cell parameters partcularly those related to
ageing (oigure 2). Including biochemical noise arising from oOCM is crucial especially if one considers
that  site  specifc  (e.g.  gene  promoter)  DNA  methylaton  events  interact  with  oOCM  within  a
microscopic rather than macroscopic environment. This microenvironment is characterised by low
molecular populatons, which react at discrete tme-points, via random collisions between individual
molecules.  The advantage of  this  framework is  its  simplicity  as  a  complex  biological  network is
reduced  to  a  much  simpler  abstracton.  A  drawback  of  this  approach  is  that  it  reduces  the
methylaton cycle and oOCM to two variables within a phenomenological model, which lumps all
sources of extrinsic noise together. Moreover, as we are concerned with the complexites of the
reactons of  folate metabolism and how changes to  these impact  DNA methylaton events,  it  is
challenging to separate this source of noise from other extrinsic events e.g. the impact of the cell
cycle. A further challenge associated with this proposal is that in order to characterise the intrinsic
noise for a given gene promoter it  would be necessary to experimentally  characterise promoter
specifc cell to cell methylaton variability in young disease free cells and how this relates to protein
expression levels. oor instance, microscopy or fow cytometry are routnely used to quantfy protein
expression  variability  in  reporter  genes  embedded  in  homogenous  cell  populatons  [118,  119].
Protein count distributons then provide an overview of cell to cell fuctuatons in gene expression.
The  stochastc  profle  can  then  be  characterised  as  the  squared  coefcient  of  variaton  of  the
fuorescence levels [120], the coefcient of variaton [113] or the oano oactor [121]. Therefore, it
would be necessary to develop experimental methods which are capable of determining the exact
nature of the stochastcity of the DNA methylaton process. However, given that DNA methylaton
levels are quantfed in a totally diferent manner to protein fuctuatons it is could be challenging to
defne/characterise  its  stochastc  signature  in  a  precise  way  experimentally.  Next  generaton
sequencing  techniques  could  help  to  alleviate  this  problem.  These  techniques  enable  the
determinaton of the methylaton status at each cytosine for a specifc segment of the genome. An
eloquent example of this approach is the work of Hansen et al. (2011) [122], who showed stochastc
methylaton of cancer-specifc DNA-methylated regions. This was able to distnguish cancer from
normal tssue. More recently Cheow et al. (2016) [123] developed a method to genotype individual
cells while concurrently probing gene expression and DNA methylaton levels at multple loci. Such
methods could help identfy an individual stochastc signature for a partcular gene promoter/gene
body, which would help inform the mathematcs underpinning future computatonal models.  An
alternatve  to  the  reduced  stochastc  model  approach  would  be  to  explicitly  represent  each
deterministc kinetc reacton within oOCM and the DNA methylaton cycle as stochastc propensity
functons  and  to  simulate  the  integrated  model  with  a  SSA  [99],  as  has  been  done  with  other
complex biochemical systems [124]. In oigure 2 part b we have created a list of reactons which could
be represented as propensity functons, where C1- C7 are indicatve of stochastc rate constants. This
is  not  unrealistc  as  mathematcal  approaches  have  been  developed  previously  for  convertng
deterministc systems biology models into stochastc models [125-127]. However, regardless of the
approach it  is our opinion that future computatonal models should combine these two systems
together. Moreover, it  is imperatve that any combined model accounts for the biochemical and
molecular variability which is inherent to both systems. This will improve our overall understanding
of how those gene promoters which appear to be susceptble to hypermethylaton interact with
both folate metabolism and the ageing process. 
Conclusions
oolate  metabolism and  the  DNA  methylaton  cycle  are  inexorably  entwined  as  the  folate  cycle
provides the methyl groups used in DNA methylaton reactons. Experimental evidence suggests the
dynamics of the folate cycle and the DNA methylaton cycle are subject to inherent stochastcity.
Investgatng  this  behaviour  is  challenging,  however  computatonal  modelling  ofers  and  ideal
framework for exploring the interactons between these two systems. In this review we proposed
building a computatonal model of folate metabolism coupled with the reactons of the methylaton
cycle. This model would help to further explore the dynamics of this relatonship and could be used
to  investgate  how  disruptons  to  these  processes  result  in  aberrant  DNA  methylaton  status,
specifcally gene promoter hypermethylaton.
Key Points 
 oolate metabolism has a vital role to play in health and possibly intrinsic ageing
 oolates  supply  methyl  groups  for  DNA methylaton reactons  which  are  central  to  gene
regulaton. 
 Dynamic computatonal models have been successfully used to study the complexites of
folate  metabolism  and  the  DNA  methylaton  cycle  respectvely,  but  no  model  has  fully
coupled both systems.  
 To  combine  both  systems  computatonally  it  is  important  to  account  for  the  inherent
stochastcity which infuences the dynamics of both systems. 
 Incorporatng  inherent  biochemical  and  molecular  variability  will  provide  an  improved
understanding of how perturbatons to these systems impact the onset of disease and will
help  to  further  elucidate  the  bidirectonal  relatonship  between  ageing  and  DNA
methylaton.
Glossary
Deterministc model A model which assumes variability does not impact the system of interest.
The model will produce the same output given the same inital conditons
and parameters. 
Extrinsic noise oluctuatons in the factors external to the biological system of interest e.g.
biochemical  fuctuatons  in  the  folate  pathway  and  its  impact  on  gene
expression. 
Gillespie algorithm An algorithm used to generate stochastc models of reacton networks.
Intrinsic noise Noise associated with a biological system of interest e.g. in the case of this 
review, site specifc DNA methylaton.
Stochastc model A model  grounded in  probability  theory which  is  used to  represent the
variability inherent in biological processes. In this review we suggest oOCM
is combined with the DNA methylaton cycle into a single stochastc model,
to capture the inherent variability in body systems.
oigure1. oolate metabolism and its intersecton with DNA Methylatonn: Ingested folates, are the cofactors for
the de novo synthesis of methyl groups. Methyl groups on 5-methyltetrahydrofolate are used to re-methylate
homocysteine  (Hcy)  to  methionine,  with  the  aid  of  vitamin  B12  and  methionine  synthase.  This  reacton
regenerates  tetrahydrofolate,  the  metabolically  actve  form  of  folate.  Methionine  is  a  precursor  of  S-
adenosylmethionine (SAM),  which  has  a  predominant  role  to  play  in  the majority  of  biochemical  methyl
donaton  events,  including  that  of  DNA  methylaton.  DNA  methyltransferase  1  is  central  to  maintaining
genomic  methylaton  paterns,  while  DNA  methyltransferase  3a  and  3b  are  both  involved  in  de  novo
methylaton reactons.  Ten eleven translocaton (TET)  dioxygenases are actvely  involved in demethylatng
cytosine, while CH3 groups are also lost passively. Pink circles indicate methylated CpG’s. 
oigure 2. Stochastc contributons to CpG island methylatonn:  Methylaton density is afected by intrinsic and
extrinsic  noise.  On  the  one  hand  noise  is  necessary  and  evoluton  has  fnely  tuned  this  system  so  that
stochastcity helps to maintain average methylaton density in young cells. However, the ageing process results
in gradual increase in stochastcity which eventually culminates with promoter hypermethylaton. During aging
gene promoter methylaton has been identfed within a wide variety of genes involved in health-span/ageing
(Refer to table 4 for full functon and descripton). Included also are the equatons which defne intrinsic and
extrinsic noise, which are discussed in the main text (Mathematcal equatons based on framework introduced
by Elowitz colleagues (2002) [113]). Part B presents a summary of the combined model represented by a set of
indicatve  reactons  which  could  be  modelled  using  propensity  functons.  Abbreviatonsn:  o,  folate;  THo,
tetrahydrofolate;  5MTHo,  5-methyltetrahyrofolate; 510MTHo,  5,10  methylenetetrahydrofolate;  Met,
methionine;  SAM,  S-adenosylmethionine;  SAH,  S-adenosylhomocysteine;  Hcy,  homocysteine;  DHo,
dihydrofolate; 10oorm, 10,formyl THo.
Tables 1 to 4. 
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